The Executive Committee and membership would like to thank David Cunningham for his stunning efforts for us over the last 5 years during which he has been chair of the Executive Committee of the ACP.
The 2023 National Clinical Impact Awards (formerly Clinical Excellence Awards) round is now open. In previous years the ACP has been able to support applications as a National Nominating Organisation. The process has changed in 2023; although the ACP no longer has a formal role, we would stongly encourage members to consider applying. You are advised to refer ... Read More...
The ACP was sad to hear of the recent death of Ken Bagshawe. A founding member of the ACP and a pioneer in the development of medical oncology in the UK, he was a consultant medical oncologist at Charing Cross and Emeritus Professor at Imperial College.
An obituary for Ken can be found here.
Read More...
National regimen-specific consent forms continue to be regularly reviewed and updated, in addition to new forms being released. New forms have recently been added for LUNG CANCER. All available forms are available on the CRUK website here.
The UK Chemotherapy Board has also recently issued new guidance on:
Hepatitis B testing - New position statement and gu... Read More...
Awarded first prize in the BMA 2022 Medical Book Awards - Oncology category. Congratulations to Lena Karapanagiotou, Janine Mansi and co-editors. Further details of this title, and others in the ACP/EBN Problem Solving series of books, here. Discounts for ACP members.
Read More...
Red blood cell stocks are currently low. The RCR and ACP have published recommendations for oncology teams for red blood cell transfusion in adults when red blood cell stocks are low. The recommendations are available here
Read More...
The ACP has collaborated with the RCR to develop a brand new e-learning resource on the Fundamentals of Cancer Genomics, targeted at medical and clinical oncologists, as well as HCPs involved in the care of patients with cancer.
Friday 14 October 2022 @ Hilton Leeds City Hotel, Leeds.
This workshop aims to highlight some of the new advances in the rapidly expanding field of biotherapies. This includes immunotherapies and novel indications, cellular therapies and technologies and advances in liquid biopsies. Presentations by leading experts will be facilitated with the case-based discussion and interactive panel discussions regarding developments and patients' cancer care.
The ACP is proud to announce that Professor Sanjay Popat, thoracic oncologist at the Royal Marsden, is a candidate for the ESMO Director of Public Policy. ESMO members should have received details of the Executive Board elections (full information and link to the electronic ballot here) and the ACP encourages you to vote.
Read More...